Dr. Oster has served as the Chairman of ImmunoGenes since August 2008. Dr. Oster has more than 25 years of experience in the healthcare sector. He started his career in academic medicine, trained in Europe and the U.S., received board certifications for internal medicine, hematology, and oncology, and served as adjunct Professor at the Brown Medical School as well as at the University of Freiburg, Germany.
Dr. Kacskovics has served as a Vice Chairman of ImmunoGenes and as the company's Chief Executive Officer since August 2008. Dr. Kacskovics received his DVM degree in 1987, and his PhD (immunology) in 1998 from the University of Veterinary Science, Budapest where he worked as a senior scientist until 2006. He spent his postdoctoral training at the University of Iowa from 1991 to 1994, and has been a visiting scientist at the Karolinska Institute since 1995. Since 2006, he has been an Associate Professor at the Department of Immunology, Eötvös Loránd University, Budapest. Dr. Kacskovics is an expert in immunoglobulins and Fc receptors areas and has been published in over 40 peer-reviewed publications.
Dr. Schalop has served as Chief Operating Advisor since 2010, a director of ImmunoGenes since August 2009 and the company's head of business development since June 2009.
Dr. Schalop is a biotech industry angel investor and entrepreneur, a role he has held since graduating with a doctor of medicine degree from the Albert Einstein College of Medicine in 2008.
Dr. Barlage has served as a director of ImmunoGenes since May 2010 and as Chief Financial Advisor since 2011.
Dr. Barlage has been Managing Partner at PolyTechnos since 2003. He adds an investment and financial analytical capability as well as an operational expertise which is truly unique.
He came to PolyTechnos as one of the most successful executives in the German Engineering field and has built the world's leading hydraulics company Sauer from its German, family-owned mid-cap beginnings to its presence on world stage and public markets. He served as President, COO, and CFO of Sauer, which he took public in 1998 (NYSE: SHS) and which merged with Danfoss Mobile Hydraulics in 2000, creating a company with more than a USD 1B market cap. Sauer is one of the world's largest manufacturers of mobile hydraulic equipment, with operations in the U.S., Europe, Eastern Europe, and Asia. Tonio created the Slovakia and China divisions.
Until 1986, he was audit division manager at Arthur Andersen in Düsseldorf, Germany. He has long standing expertise as a board member and his current appointments include DBD, Nanotron, Innolume, and Panoratio, as well as Framepool.
Dr. Barlage received his graduate degree in electrical engineering and his Ph.D. in business administration from the Technical University of Berlin. He also is a Certified Public Accountant and a Certified Tax Adviser.